Dear Women's Imaging Insider,
More than 40% of women who are eligible for breast cancer screening have dense tissue, and because dense tissue can limit 2D mammography's performance, it's important to offer these women supplemental imaging. But which modality is best?
Researchers from the Mayo Clinic in Rochester, MN, argue that molecular breast imaging (MBI) may be an underutilized technology for finding cancer in dense tissue. Click here to find out why MBI could be an effective addition to your screening practice.
When you're finished with our Insider Exclusive, check out what else is going on in the Women's Imaging Community:
- Find out why false positives on mammography may suggest that a woman is at increased risk for breast cancer.
- Discover why researchers from the University of California, San Francisco say that comparing screening mammography with two or more prior exams reduces the odds that a woman will be recalled.
- Read about how breast MR can help find aggressive cancers that mammography misses -- and may prompt a change in a patient's treatment plan.
- Get the scoop on new guidance from the U.S. Food and Drug Administration about whether film printing is necessary for mammography exams.
- Finally, forget about artificial intelligence taking your job: It's the pigeons you should worry about. Discover what researchers found about the birds' ability to distinguish benign from malignant tissue on breast cancer pathology slides and images.
As always, if you have a comment, report, or article idea to share about any aspect of women's imaging, please contact me.
